Newer Dopaminergic Agents Cause Minimal Endocrine Effects in Idiopathic Parkinson’s Disease

OBJECTIVE: We studied the prevalence of endocrine dysfunction in subjects with idiopathic Parkinson’s disease (IPD) on newer dopaminergic agents (DA). DA are also used in endocrine hypersecretory states in small doses and we hypothesized that endocrine dysfunction was likely in IPD where DA were use...

Descripción completa

Detalles Bibliográficos
Autores principales: Daniel, Jacob S, Govindan, Jyothish P, Kamath, Chandan, D’Souza, Charles, Adlan, Mohamed A, Premawardhana, Lakdasa D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011722/
https://www.ncbi.nlm.nih.gov/pubmed/24855402
http://dx.doi.org/10.4137/CMED.S14902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011722/
https://www.ncbi.nlm.nih.gov/pubmed/24855402
http://dx.doi.org/10.4137/CMED.S14902

Ejemplares similares